S'abonner

A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: Rationale and initial results of the HIJAMI Registry - 21/08/11

Doi : 10.1016/j.ahj.2004.10.001 
Hiroshi Kasanuki, MD a, Takashi Honda, MD b, Kazuo Haze, MD c, Tetsuya Sumiyoshi, MD d, Toshinobu Horie, MD e, Masahiro Yagi, MD a, Jun-ichi Yamaguchi, MD a, Yasuhiro Ishii, MD a, Shin-ya Fujii, MD a, Michitaka Nagashima, MD a, Hisayuki Okada, MD a, Hiroshi Koganei, MD a, Ryo Koyanagi, MD a, Yukio Tsurumi, MD a, Hirotaka Kimura, MD a, Hiroshi Ogawa, MD a,

for the HIJAMI InvestigatorsTokyo, Kumamoto, Osaka, and Saitama, Japan

a Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan 
b Division of Cardiology, Cardiovascular Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan 
c Division of Cardiology, Osaka City General Hospital, Osaka, Japan 
d Department of Cardiology, The Sakakibara Heart Institute, Japan 
e Department of Cardiology, Saitama Cardiovascular and Respiratory Center, Saitama, Japan 

Reprint requests: Hiroshi Ogawa, MD, Nihon Iryo Suishin Jigyodan, So-Go Hanzo-Mon Building, First floor, 1-7, Koji-Machi, Chiyoda-Ku, Tokyo 102-0083, Japan.

Résumé

Background

In Western countries, several multicenter collaborative studies on acute myocardial infarction (AMI) have provided much information about this disease. In Japan, on the other hand, there have been few cohort studies in which a sufficient number of Japanese patients with AMI were registered during a short period. This fact explains the absence of a database from which strategies for treating Japanese patients with AMI could be established. The purpose of this study was to build a comprehensive database on Japanese patients with AMI to elucidate their characteristics.

Methods

Between January 1999 and June 2001, we consecutively registered all patients with AMI who were admitted to 17 participating medical institutions, including The Heart Institute of Japan, Cardiology (HIJC), Tokyo Women's Medical University. A standardized case report form was used to register all the patients.

Results

A total of 3021 consecutive patients was registered (2136 men, 70.7%; 885 women, 29.3%) with a median age of 69 years [59, 77]. Among the patients, there were 851 elderly individuals (28.2%) ≥76 years and 1102 patients with diabetes (36.5%). On index electrocardiogram, ST-elevation myocardial infarction was observed in 2392 patients (79.2%). Within 24 hours after the onset of AMI, coronary angiography was conducted for 2177 patients (72.1%). Primary percutaneous coronary intervention and coronary thrombolysis were conducted for 1755 (58.1%) and 491 patients (16.3%), respectively, and percutaneous coronary intervention or coronary artery bypass grafting was additionally carried out in 303 patients. By the time of discharge, coronary angiography and coronary artery bypass grafting were performed in 2659 (88.0%) and 137 patients (4.5%), respectively. During initial hospitalization, 285 patients died and the overall inhospital mortality rate was 9.4%. During hospitalization, cardiogenic shock and cardiac rupture were observed in 6.1% and 2.8% of the patients, respectively. The inhospital mortality rate is still high in patients with AMI with such mechanical complications and in elderly patients.

Conclusion

In our prospective cohort, we showed that Japanese patients with AMI could be characterized as (1) having a disease severity comparable with values observed in Western populations and (2) receiving early reperfusion therapy by PCI, which was used widely and safely, but nevertheless (3) exhibiting a high inhospital mortality rate. Our data indicate that further improvements in therapy for AMI in elderly patients and for AMI with mechanical complications are essential in Japan.

Le texte complet de cet article est disponible en PDF.

Plan


© 2005  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 150 - N° 3

P. 411-418 - septembre 2005 Retour au numéro
Article précédent Article précédent
  • Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients
  • Saif S. Rathore, Kevin P. Weinfurt, JoAnne M. Foody, Harlan M. Krumholz
| Article suivant Article suivant
  • Association between lipid testing and statin therapy in acute myocardial infarction patients
  • Dennis T. Ko, David A. Alter, Alice M. Newman, Linda R. Donovan, Jack V. Tu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.